Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of prognostic gene expression signatures for breast cancer.
Haibe-Kains B, Desmedt C, Piette F, Buyse M, Cardoso F, Van't Veer L, Piccart M, Bontempi G, Sotiriou C. Haibe-Kains B, et al. Among authors: bontempi g. BMC Genomics. 2008 Aug 21;9:394. doi: 10.1186/1471-2164-9-394. BMC Genomics. 2008. PMID: 18717985 Free PMC article.
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.
Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, Gillet C, Ellis P, Harris A, Bergh J, Foekens JA, Klijn JG, Larsimont D, Buyse M, Bontempi G, Delorenzi M, Piccart MJ, Sotiriou C. Loi S, et al. Among authors: bontempi g. J Clin Oncol. 2007 Apr 1;25(10):1239-46. doi: 10.1200/JCO.2006.07.1522. J Clin Oncol. 2007. PMID: 17401012
4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs.
Mégalizzi V, Mathieu V, Mijatovic T, Gailly P, Debeir O, De Neve N, Van Damme M, Bontempi G, Haibe-Kains B, Decaestecker C, Kondo Y, Kiss R, Lefranc F. Mégalizzi V, et al. Among authors: bontempi g. Neoplasia. 2007 May;9(5):358-69. doi: 10.1593/neo.07130. Neoplasia. 2007. PMID: 17534441 Free PMC article.
Evidence of galectin-1 involvement in glioma chemoresistance.
Le Mercier M, Lefranc F, Mijatovic T, Debeir O, Haibe-Kains B, Bontempi G, Decaestecker C, Kiss R, Mathieu V. Le Mercier M, et al. Among authors: bontempi g. Toxicol Appl Pharmacol. 2008 Jun 1;229(2):172-83. doi: 10.1016/j.taap.2008.01.009. Epub 2008 Jan 29. Toxicol Appl Pharmacol. 2008. PMID: 18313712
Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity.
Mijatovic T, De Nève N, Gailly P, Mathieu V, Haibe-Kains B, Bontempi G, Lapeira J, Decaestecker C, Facchini V, Kiss R. Mijatovic T, et al. Among authors: bontempi g. Mol Cancer Ther. 2008 May;7(5):1285-96. doi: 10.1158/1535-7163.MCT-07-2241. Mol Cancer Ther. 2008. PMID: 18483316 Free article.
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.
Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, Daidone MG, Pierotti MA, Berns EM, Jansen MP, Foekens JA, Delorenzi M, Bontempi G, Piccart MJ, Sotiriou C. Loi S, et al. Among authors: bontempi g. BMC Genomics. 2008 May 22;9:239. doi: 10.1186/1471-2164-9-239. BMC Genomics. 2008. PMID: 18498629 Free PMC article.
85 results